Evidence map›Paper›PMID 27115820›Full record

ReviewLancet (London, England)2016

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants.

NCD Risk Factor Collaboration (NCD-RisC)

Erratum issued 3 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Lancet (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 3 registered trials, which are not on this map. Cited by 2,414 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,414citing papers in PubMed, 7 pooled it
1214.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06606821 phase4recruitingstarted 2024, after this paper: background citation

The Effects of Tirzepatide on Coronary Plaque Lipid Content and Myocardial Microvascular Function in Overweight and Obese People With Coronary Disease - The IDEAL-COR Study

Ran2024Enrolled124Registered outcomes23Posted comparisons0ConditionsAtherosclerosis Cardiovascular Disease, Chronic Coronary Artery Disease, Coronary Artery Disease, Coronary Microvascular DysfunctionArmsPlacebo, Tirzepatide
Open the trial in the graph
NCT04602572 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Obesity and Oral Diseases in Adult Patients

TypeobservationalSponsorUniversity of BergenRan2026 to 2027Enrolled400ConditionsObesity, Oral Diseases, Periodontitis, Dental CariesArmsLifestyle course., Bariatric surgery.
NCT07101133 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Research on Key Technologies of Precision Nutrition for Obesity Intervention

TypeinterventionalSponsorYuan HeRan2025 to 2027Enrolled600ConditionsObesity and Obesity-related Medical ConditionsArmsControl group: Energy-limited balanced diet group
3 · Its place in the literature

Who cites it

2,414 citing papers in PubMed, 7 syntheses or guidelines pooled it, 5,221 citations in OpenAlex.

  1. Pooled it
  2. Efficacy of Weight-Lowering Agents on Fat Distribution: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Gut microbes · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

2,354 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 2 institutions in 2 countries.

NCD Risk Factor Collaboration (NCD-RisC)
Biomechanics Institute of Valencia · ESNutrition Sciences (Belgium) · BE

Funding

British Heart Foundation PG/05/046/18730British Heart Foundation PG/13/66/30442Medical Research Council G0400491Medical Research Council G0400519Medical Research Council G0401527Medical Research Council MC_U106179471Medical Research Council MC_U147574245Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UP_A620_1015Medical Research Council MC_UP_A620_1016Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12011/2Medical Research Council MC_UU_12011/3Medical Research Council MC_UU_12011/4Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12019/1Medical Research Council MR/K006584/1Medical Research Council MR/L01341X/1Medical Research Council MR/N003284/1Wellcome Trust 100693Wellcome Trust 101506
6 · The paper itself

Abstract

backgroundUnderweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean body-mass index (BMI), which characterises its population distribution, and in the prevalences of a complete set of BMI categories for adults in all countries.

methodsWe analysed, with use of a consistent protocol, population-based studies that had measured height and weight in adults aged 18 years and older. We applied a Bayesian hierarchical model to these data to estimate trends from 1975 to 2014 in mean BMI and in the prevalences of BMI categories (<18·5 kg/m(2) [underweight], 18·5 kg/m(2) to <20 kg/m(2), 20 kg/m(2) to <25 kg/m(2), 25 kg/m(2) to <30 kg/m(2), 30 kg/m(2) to <35 kg/m(2), 35 kg/m(2) to <40 kg/m(2), ≥40 kg/m(2) [morbid obesity]), by sex in 200 countries and territories, organised in 21 regions. We calculated the posterior probability of meeting the target of halting by 2025 the rise in obesity at its 2010 levels, if post-2000 trends continue.

findingsWe used 1698 population-based data sources, with more than 19·2 million adult participants (9·9 million men and 9·3 million women) in 186 of 200 countries for which estimates were made. Global age-standardised mean BMI increased from 21·7 kg/m(2) (95% credible interval 21·3-22·1) in 1975 to 24·2 kg/m(2) (24·0-24·4) in 2014 in men, and from 22·1 kg/m(2) (21·7-22·5) in 1975 to 24·4 kg/m(2) (24·2-24·6) in 2014 in women. Regional mean BMIs in 2014 for men ranged from 21·4 kg/m(2) in central Africa and south Asia to 29·2 kg/m(2) (28·6-29·8) in Polynesia and Micronesia; for women the range was from 21·8 kg/m(2) (21·4-22·3) in south Asia to 32·2 kg/m(2) (31·5-32·8) in Polynesia and Micronesia. Over these four decades, age-standardised global prevalence of underweight decreased from 13·8% (10·5-17·4) to 8·8% (7·4-10·3) in men and from 14·6% (11·6-17·9) to 9·7% (8·3-11·1) in women. South Asia had the highest prevalence of underweight in 2014, 23·4% (17·8-29·2) in men and 24·0% (18·9-29·3) in women. Age-standardised prevalence of obesity increased from 3·2% (2·4-4·1) in 1975 to 10·8% (9·7-12·0) in 2014 in men, and from 6·4% (5·1-7·8) to 14·9% (13·6-16·1) in women. 2·3% (2·0-2·7) of the world's men and 5·0% (4·4-5·6) of women were severely obese (ie, have BMI ≥35 kg/m(2)). Globally, prevalence of morbid obesity was 0·64% (0·46-0·86) in men and 1·6% (1·3-1·9) in women.

interpretationIf post-2000 trends continue, the probability of meeting the global obesity target is virtually zero. Rather, if these trends continue, by 2025, global obesity prevalence will reach 18% in men and surpass 21% in women; severe obesity will surpass 6% in men and 9% in women. Nonetheless, underweight remains prevalent in the world's poorest regions, especially in south Asia.

fundingWellcome Trust, Grand Challenges Canada.

Indexed as

Body Mass IndexGlobal HealthAdolescentAdultBayes TheoremDeveloped CountriesDeveloping CountriesFemaleForecastingHumansMaleModels, StatisticalObesityPrevalenceThinnessYoung Adult

Identifiers

PMID27115820
PMCPMC7615134
OpenAlexW2341244791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.